BeyondSpring Announces First Patient Enrolled in Phase 1b/2 Investigator-Initiated Trial of Plinabulin plus Nivolumab for Non-Small Cell Lung Cancer

… patients with metastatic non-small cell lung cancer (NSCLC) was enrolled on September … approximately 85 percent of all lung cancer cases."
About BeyondSpring Pharmaceuticals … anticancer agent in non-small cell lung cancer. The Company is also planning …